Skip to main content

Main menu

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
  • Other Publications
    • The Journal of Applied Laboratory Medicine

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Clinical Chemistry
  • Other Publications
    • The Journal of Applied Laboratory Medicine
  • Subscribe
  • My alerts
  • Log in
Clinical Chemistry

Advanced Search

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
OtherSpecial Report

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

John H. Contois, Joseph P. McConnell, Amar A. Sethi, Gyorgy Csako, Sridevi Devaraj, Daniel M. Hoefner, G. Russell Warnick
DOI: 10.1373/clinchem.2008.118356 Published February 2009
John H. Contois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph P. McConnell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amar A. Sethi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gyorgy Csako
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sridevi Devaraj
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel M. Hoefner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Russell Warnick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 55 no. 3 407-419
DOI 
https://doi.org/10.1373/clinchem.2008.118356
PubMed 
19168552

Published By 
Clinical Chemistry
Print ISSN 
0009-9147
Online ISSN 
1530-8561
History 
  • Published online February 25, 2009.

Article Versions

  • Latest version (January 23, 2009 - 05:58).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 The American Association for Clinical Chemistry

Author Information

  1. John H. Contois1,a,2,
  2. Joseph P. McConnell2,
  3. Amar A. Sethi3,
  4. Gyorgy Csako3,
  5. Sridevi Devaraj4,
  6. Daniel M. Hoefner5 and
  7. G. Russell Warnick6
  1. 1Maine Standards Company, Windham, ME;2 Mayo Clinic, Rochester, MN;3 National Institutes of Health, Bethesda, MD;4 UC Davis Medical Center, Sacramento, CA;5 Marshfield Clinic, Marshfield, WI;6 Berkeley HeartLab Inc, Alameda, CA.
  1. ↵aAddress correspondence to this author at: Maine Standards Company LLC, 765 Roosevelt Trail, Windham, ME 04062. Fax 207-892-2266; e-mail jcontois{at}mainestandards.com.
View Full Text

PreviousNext
Back to top

In this issue

Clinical Chemistry: 55 (3)
Vol. 55, Issue 3
March 2009
  • Table of Contents
  • Index by author
  • Table of Contents (PDF)
  • Cover (PDF)
  • Advertising (PDF)
  • Ed Board (PDF)
Print
Share
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
John H. Contois, Joseph P. McConnell, Amar A. Sethi, Gyorgy Csako, Sridevi Devaraj, Daniel M. Hoefner, G. Russell Warnick
Clinical Chemistry Mar 2009, 55 (3) 407-419; DOI: 10.1373/clinchem.2008.118356
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
John H. Contois, Joseph P. McConnell, Amar A. Sethi, Gyorgy Csako, Sridevi Devaraj, Daniel M. Hoefner, G. Russell Warnick
Clinical Chemistry Mar 2009, 55 (3) 407-419; DOI: 10.1373/clinchem.2008.118356

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • apo b-containing lipoproteins and cvd risk
    • apo b structure and function
    • apo b genetics
    • disorders of apo b
    • prospective studies of apo b in primary and secondary prevention
    • ldl-lowering treatment and residual cvd risk
    • management of ldl-related risk
    • non-hdl cholesterol
    • measurement issues
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
  • Identifying and Eliminating Laboratory Contamination by Topical Testosterone Therapeutics
  • Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis
Show more Special Report

Similar Articles

Subjects

  • OTHER INTEREST
    • Special Interest Papers for ACC Cardiologists
  • TRANSLATED CONTENT
    • Italian Translations

Options

  • Home
  • About
  • Articles
  • Information for Authors
  • Resources
  • Abstracts
  • Submit
  • Contact
  • RSS

Other Publications

  • The Journal of Applied Laboratory Medicine
Footer logo

© 2019 American Association for Clinical Chemistry

Powered by HighWire